Wells Fargo & Company Glaukos Corp Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024

A detailed history of Wells Fargo & Company transactions in Glaukos Corp stock. As of the latest transaction made, Wells Fargo & Company holds 24,329 shares of GKOS stock, worth $3.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,329
Previous 19,070 27.58%
Holding current value
$3.2 Million
Previous $1.8 Million 60.12%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$89.48 - $118.35 $470,575 - $622,402
5,259 Added 27.58%
24,329 $2.88 Million
Q1 2024

May 10, 2024
BUY
$76.4 - $96.33 $45,840 - $57,798
600 Added 3.25%
19,070 $1.8 Million
Q4 2023

Feb 09, 2024
BUY
$59.53 - $85.11 $429,270 - $613,728
7,211 Added 64.05%
18,470 $1.47 Million
Q3 2023

Nov 13, 2023
SELL
$69.23 - $79.09 $874,859 - $999,460
-12,637 Reduced 52.88%
11,259 $847,000
Q2 2023

Aug 15, 2023
BUY
$45.44 - $71.21 $479,301 - $751,123
10,548 Added 79.02%
23,896 $1.7 Million
Q1 2023

May 12, 2023
BUY
$43.88 - $52.48 $371,224 - $443,980
8,460 Added 173.08%
13,348 $668,000
Q4 2022

Feb 13, 2023
SELL
$40.82 - $57.75 $90,416 - $127,916
-2,215 Reduced 31.18%
4,888 $213,000
Q3 2022

Nov 14, 2022
SELL
$46.84 - $58.49 $54,521 - $68,082
-1,164 Reduced 14.08%
7,103 $378,000
Q2 2022

Aug 12, 2022
SELL
$34.86 - $63.77 $647,280 - $1.18 Million
-18,568 Reduced 69.19%
8,267 $375,000
Q1 2022

May 16, 2022
SELL
$44.33 - $57.82 $8.25 Million - $10.8 Million
-186,145 Reduced 87.4%
26,835 $1.55 Million
Q4 2021

Feb 14, 2022
BUY
$40.27 - $56.99 $101,762 - $144,013
2,527 Added 1.2%
212,980 $9.46 Million
Q3 2021

Nov 15, 2021
BUY
$47.43 - $84.23 $6 Million - $10.7 Million
126,573 Added 150.9%
210,453 $10.1 Million
Q2 2021

Aug 16, 2021
BUY
$73.06 - $97.7 $689,905 - $922,581
9,443 Added 12.69%
83,880 $7.12 Million
Q1 2021

May 13, 2021
SELL
$70.43 - $97.42 $1.66 Million - $2.29 Million
-23,547 Reduced 24.03%
74,437 $6.25 Million
Q4 2020

Feb 09, 2021
SELL
$48.9 - $75.26 $4.29 Million - $6.59 Million
-87,628 Reduced 47.21%
97,984 $7.37 Million
Q3 2020

Nov 05, 2020
BUY
$37.23 - $50.97 $1.18 Million - $1.61 Million
31,597 Added 20.52%
185,612 $9.19 Million
Q2 2020

Aug 13, 2020
BUY
$28.78 - $46.83 $465,516 - $757,475
16,175 Added 11.73%
154,015 $5.92 Million
Q1 2020

May 14, 2020
BUY
$25.53 - $70.14 $3.52 Million - $9.67 Million
137,840 New
137,840 $4.25 Million

Others Institutions Holding GKOS

# of Institutions
310
Shares Held
46.8M
Call Options Held
75.3K
Put Options Held
157K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.25B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email